Radium-223 therapy in symptomatic metastatic castrate resistant prostate cancer (mCRPC) – sequential use post-abiraterone/prednisolone
2019
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI